Antibiotic management of pneumococcal infections in an era of increased resistance

Journal of Paediatrics and Child Health

Volumn 33, Issue 4, 1997, Pages 287-295

  Grimwood, K ^a   Collignon, P J ^a   Currie, B J ^a   Ferson, M J ^a   Gilbert, G L ^a   Hogg, G G ^a   Isaacs, D ^a,b   Mcintyre, P B ^a  

^a Australasian Soc for Infect Dis   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Antibiotics; Pneumococci; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBACEPHEM DERIVATIVE; CEFACLOR; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; ROXITHROMYCIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; CHILD; CHILDHOOD DISEASE; DRUG PENETRATION; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PENICILLIN ALLERGY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030774476     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01602.x     Document Type: Review

References (87)

1. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: Implications for therapy and prevention. JAMA 1996; 275: 194-8.
2. Shann F. The management of pneumonia in children in developing countries. Clin. Infect. Dis. 1995; 21 (Suppl 3): S218-25.
3. Peltola H, Kilpi T, Antilla M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340; 592-4.
4. Lonks JR, Medeiros AA. The growing threat of antibiotic-resistant Streptococcus pneumoniae. Med. Clin. North. Amer. 1995; 79: 523-35.
5. John CC. Treatment failure with use of a third-generation cephalosporin for penicillin- resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 1994; 18: 188-93.
6. Gray BM, Converse GM, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 1980; 142: 923-33.
7. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Matthews JD. Bacterial colonizaton of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr. Infect. Dis. J. 1994; 13: 983-9.
8. Hogg GG, Strachan J, McBride J, Stylianopoulos J. Epidemiology of invasive pneumococcal disease in Victoria, Australia. [Abstract 126.004]. In: Proceedings of the 7th International Congress for Infectious Diseases, Hong Kong. International Society for Infectious Diseases, 1996; 321-2.
9. Voss L, Lennon D, Okesene-Gafa K, Ameratunga S, Martin D. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr. Infect. Dis. J. 1994; 13: 873-8.
10. Eskola J, Takala AK, Kela E, Pekkanen E, Kallioski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268: 3323-7.
11. Istre GR, Tarpay M, Anderson M et al. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J. Infect. Dis. 1987; 156: 732-5.
12. Torzillo PJ, Hanna JN, Morey F, Gratten M, Dixon J, Erlich J. Invasive pneumococcal disease in central Australia. Med. J. Aust. 1995; 162: 182-6.
13. Takala AK, Jero J, Kela E, Ronnberg P-R, Koskenniemi E, Eskola J. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA 1995; 273: 859-64.
14. Davis CWC, McIntyre PB. Invasive pneumococcal infection in children, 1981-92: A hospital-based study. J. Paediatr. Child Health 1995; 31: 317-22.
15. Martin DR, Brett MS. Pneumococci causing invasive disease in New Zealand 1987-94: Serogroup and serotype coverage and antibiotic resistances. NZ Med. J. 1996; 108: 288-90.
16. Gratten M, Torzillo P, Morey F et al. Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in Central Australia. J. Clin. Microbiol. 1996; 34: 338-41.
17. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A3, ed 3. Villanova, PA, NCCLS, 1993.
18. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; ii: 264-5.
19. Hansman D, Devitt L, Riley I. Pneumococci with increased resistance to penicillin. BMJ 1973; 3: 405.
20. Cybulska J, Jeljaszewicz J, Lund E, Munksgaard A. Prevalence of types of Diplococcus pneumoniae and their suscepitibility to 30 antibiotics. Chemotherapy 1970; 15: 304-16.
21. Jacobs MR, Koornhoff HJ, Robins-Browne RM et al. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 1978; 299: 735-40.
22. Schreiber JR, Jacobs MR. Antibiotic-resistant pneumococci. Pediatr. Clin. North Amer. 1995; 42: 519-37.
23. Ridgway EJ, Tremlett CH, Allen KD. Capsular serotypes and antibiotic sensitivity of Streptococcus pneumoniae isolated from primary-school children. J. Infection 1995; 30: 245-51.
24. McCracken GH. Emergence of resistant Streptococcus pneumoniae: A problem in paediatrics. Pediatr. Infect. Dis. J. 1995; 14: 424-8.
25. Collignon PJ, Bell JM. Drug-resistant Streptococcus pneumoniae; the beginning of the end for many antibiotics? Med. J. Aust. 1996; 164: 64-7.
26. Brett M. Antimicrobial resistance: a potential threat for New Zealand. NZ Public Health Rep. 1995; 2: 59-60.
27. Skull SA, Leach AJ, Currie BJ. Streptococcus pneumoniae carriage and penicillin/ ceftriaxone resistance in hospitalised children in Darwin. Aust. N.Z. J. Med. 1996; 26: 391-5.
28. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J. Infect. Dis. 1995; 171: 890-6.
29. Hofmann J, Cetron MS, Farley MM et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 1995; 333: 481-6.
30. Block SL, Harrison CJ, Hedrick JA et al Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 1995; 14: 751-9.
31. Arnold KE, Leggiadro RJ, Breiman RF et al. Risk factors for carriage of drug resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J. Pediatr. 1996; 1128: 757-64.
32. Steele RW, Warrier R, Unkel PJ et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J. Pediatr. 1996; 128: 531-5.
33. Arason V, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996; 313: 387-91.
34. Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: An epidemiological survey in France, 1979-90. Clin. Infect. Dis. 1992; 15: 95-8.
35. Leach AJ, Shelby-James T, Mayo M, Gratten M, Laming AC, Currie BJ, Matthews JD. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae: more than meets the eye. Clin. Infect. Dis. (in press).
36. Leach AJ, Shelby-James T, Mayo M, Gratten M, Matthews JD. Report of a multidrug resistant clone of Streptococcus pneumoniae (MRSpn) in Aboriginal infants in the Northern Territory. CDI 1995; 19: 134-7.
37. Coffey TJ, Dowson CG, Daniels M, Spratt B. Genetics and molecular biology of ß- lactam resistant pneumococci. Microb. Drug Resist. 1995; 1: 29-34.
38. Tomasz A. The pneumococcus at the gates. N. Engl. J. Med. 1995; 333: 514-5.
39. Gold HS, Moellering RC. Antimicrobial-drug resistance. N. Engl. J. Med. 1996; 335: 1445-53.
40. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multi-resistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 1993; 168: 158-63.
41. Austrian R. Confronting drug-resistant pneumococci. Ann. Intern. Med. 1994; 121: 807-9.
42. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective antibiotic concentrations of ß-lactams for penicillin-resistant streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 1994; 38: 122-5.
43. Goldstein FW, Acar JF and the Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: Results of a 1992-3 Western Europe and USA collaborative surveillance study. J. Antimicrob. Chemother. 1996; 38 (Suppl. A): 71-84.
44. Klugman KP. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 1990; 3: 171-96.
45. Friedland IR, Istre GR. Management of penicillin-resistant pneumococcal infections. Pediatr. Infect. Dis. J. 1992; 11: 1433-5.
46. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP working group. JAMA 1996; 275: 206-9.
47. Mason EO. Penicillin-resistant pneumococci: How big is the problem? Clin. Microbiol. News 1993; 15: 116-9.
48. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swensen JM, Tenover FC. Detection of penicillin and third generation cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J. Clin. Microbiol.1994; 32: 159-63.
49. Gray BM. Pneumococcal infections in an era of multiple antibiotic resistance. Adv. Pediatr. infect. Dis. 1996; 11: 55-99.
50. Friedland IR, McCracken GH. Management of infections caused by antibiotic- resistant Streptococcus pneumoniae. N. Engl. J. Med. 1994; 331: 377-82.
51. Jadavi T, Biggar WD, Gold R, Prober CG. Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics 1986; 78: 21-5.
52. Schaad UB, McCracken GH, Loock CA, Thomas ML. Pharmacokinetics and bacteriologic efficacy of moxolactam, cefotaxime, cefoperazone and rocephin in experimental bacterial meningitis. J. Infect. Dis. 1981; 143: 156-63.
53. Raymond J, Bingen E, Doit C et al. Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis. Clin. Infect. Dis. 1995; 21: 234-5.
54. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992; 339: 405-8.
55. Asensi F, Perez-Tamarit D, Otero MC et al. Imipenem-cilistatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr. Infect. Dis. J. 1989; 8: 895.
56. Klugman KP, Dagan R, the Meropenem Meningitis Study Group. Randomized comparison of meropenem with cefotaxime for bacterial meningitis. Antimicrob. Agents Chemother. 1995; 39: 1140-6.
57. Viladrich PF, Gudiol F, Linares J et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 1991; 35: 2467-72.
58. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 1995; 39: 1988-92.
59. Selby A, Isaacs D, Gillis J et al. Lumbar punctures in suspected bacterial meningitis: too many or too few? J. Paediatr. Child Health 1994; 30: 160-4.
60. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD. Meningitis with beta-lactam- resistant Streptococcus pneumoniae: The need for early lumbar puncture. Pediatr. Infect. Dis. J. 1993; 12: 782-4.
61. Jacobs RF, Stimson JM. Presumptive antibiotic therapy for hospitalized children with sepsis and meningitis: Cost effective analysis and antibiotic restriction guidelines. Pediatr. Ann. 1996; 25: 631-8.
62. Pallares R, Linares J, Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 1995; 333: 474-80.
63. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin- resistant and penicillin-susceptible pneumococcal disease. Pediatr. Infect. Dis. J. 1995; 14: 885-90.
64. Douglas RM, Miles H, Hansman D, Moore B, English DT. Microbiology of acute otitis media. Med. J. Aust. 1980; 1: 263-6.
65. Klein JO. Otitis media. Clin. Infect. Dis. 1994; 19: 823-33.
66. Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: Implications for treatment. Pediatr. Infect. Dis. J 1994; 13: 585-9.
67. Rosenfeld RM, Vertrees JE, Carr J et al. Clinical efficacy of antimicrobial drugs for acute otitis media: Metaanalysis of 5400 children from 33 randomized trials. J. Pediatr. 1994; 124: 355-67.
68. Kaleida PH, Casselbrant ML, Rockette HE et al. Amoxiciilin or myringotomy or both for acute otitis media; Results of a randomized clinical trial. Pediatrics 1991; 87: 66-74.
69. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr. Infect. Dis. J. 1993; 12: 73-5.
70. Bluestone CD. Current therapy for otitis media and criteria for evaluation of new antimicrobial agents. Clin. Infect. Dis. ; 14 (Suppl 2): 197-211.
71. Lewis K, Cherry JD. Mastoiditis. In Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. WB Saunders Co., Philadelphia, 1992; 189-95.
72. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect, Dis. J. 1996; 15: 255-9.
73. Chopra I, Hodgson J, Metcalf B, Poste G. New approaches to the control of infections caused by antibiotic-resistant bacteria. JAMA 1996; 275: 401-3.
74. Koornhoff HJ, Wasas A, Klugman K. Antimicrobial resistance in Streptococcus pneumoniae: A South African perspective. Clin. Infect. Dis. 1992; 15: 84-94.
75. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, day-care center. Am J. Dis. Child. 1990; 144: 923-7.
76. Reichler MR, Rakovsky J, Slacikova M et al. Spread of multidrug-resistant streptococcus pneumoniae among hospitalized children in Slovakia. J. Infect. Dis. 1996; 173: 374-9.
77. Kristinsson KG, Hjalmarsdottir MA, Gudnason T. Epidemiology of penicillin-resistant pneumococci (PRP) in Iceland - hope for the future? [Absrtact C9]. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1995; 41.
78. Bridges-Webb C. Morbidity and treatment in general practice in Australia 1990-1. 8. Prescriptions. Med. J. Aust. 1992; 157 (Suppl): S33-42.
79. Baraff LJ, Bass JW, Fleisher GR et al. Practice guideline for the management of infants and children 0-36 months of age with fever without source. Pediatrics 1993; 92: 1-12.
80. Fleisher GR, Rosenberg N, Vinci R et al. Intramuscular vs. oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J. Pediatr. 1994; 124: 504-12.
81. Long SS. Antibiotic therapy in febrile children: 'Best-laid schemes...' J. Pediatr. 1994; 124: 585-8.
82. Isaacs D. Occult bacteremia or occult clinical acumen? Curr. Opin. Pediatr. 1996; 8: 1-2.
83. Paradise JL. Managing otitis media: a time for change. Pediatrics 1995; 96: 712-5.
84. Gaston MH, Verter JI, Woods G et al. Prophylaxis with oral penicillin in children with sickle cell anaemia: a randomised trial. N. Engl. J. Med. 1986; 314: 1593-9.
85. Read RC, Finch RG. Prophylaxis after splenectomy. J. Antimicrob. Chemother. 1994; 33: 4-6.
86. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenecity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatr. 1996; 128: 649-53.
87. Munford RS, Murphy TV. Antimicrobial resistance in Streptococcus pneumoniae: Can immunization prevents its spread? J. Investig. Med. 1994; 42: 613-21.